Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

Guizhi Jia; Yan Wang; Chengjie Lin; Shihui Lai; Hongliang Dai; Zhiqian Wang; Luo Dai; Huizhao Su; Yanjie Song; Naiwen Zhang; Yukuan Feng; Bo Tang

doi:10.1186/s13046-023-02626-z

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

J Exp Clin Cancer Res. 2023 Mar 2;42(1):54. doi: 10.1186/s13046-023-02626-z.

Authors

Guizhi Jia^#^{1

2}, Yan Wang^#^{1

2}, Chengjie Lin^#^{1

2}, Shihui Lai^{1

2}, Hongliang Dai^{1

2}, Zhiqian Wang^{1

2}, Luo Dai^{1

2}, Huizhao Su^{1

2}, Yanjie Song^{3

4}, Naiwen Zhang^{3

4}, Yukuan Feng^{5

6}, Bo Tang^{7

8}

Affiliations

¹ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, Guangxi, People's Republic of China.
² Key Laboratory of Basic and Clinical Application Research for Hepatobiliary Diseases of Guangxi, 530021, Nanning, Guangxi, People's Republic of China.
³ Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, 300060, Tianjin, People's Republic of China.
⁴ Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, School of Basic Medicine, Mudanjiang Medical University, 157011, Mudanjiang, People's Republic of China.
⁵ Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, 300060, Tianjin, People's Republic of China. [email protected].
⁶ Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, School of Basic Medicine, Mudanjiang Medical University, 157011, Mudanjiang, People's Republic of China. [email protected].
⁷ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, Guangxi, People's Republic of China. [email protected].
⁸ Key Laboratory of Basic and Clinical Application Research for Hepatobiliary Diseases of Guangxi, 530021, Nanning, Guangxi, People's Republic of China. [email protected].

^# Contributed equally.

No abstract available

Publication types

Retraction Notice